BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36883415)

  • 1. Bacteremia in patients with diabetic ketoacidosis: a cross-sectional study.
    Ishimaru N; Shimokawa T; Nakajima T; Kanzawa Y; Kinami S
    Hosp Pract (1995); 2023 Apr; 51(2):95-100. PubMed ID: 36883415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, microbiology, and diagnosis of infection in diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: A multicenter retrospective observational study.
    Takahashi K; Uenishi N; Sanui M; Uchino S; Yonezawa N; Takei T; Nishioka N; Kobayashi H; Otaka S; Yamamoto K; Yasuda H; Kosaka S; Tokunaga H; Fujiwara N; Kondo T; Ishida T; Komatsu T; Endo K; Moriyama T; Oyasu T; Hayakawa M; Hoshino A; Matsuyama T; Miyamoto Y; Yanagisawa A; Wakabayashi T; Ueda T; Komuro T; Sugimoto T; Sasabuchi Y
    Diabetes Res Clin Pract; 2024 Jun; 212():111713. PubMed ID: 38772502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study.
    Pasquel FJ; Tsegka K; Wang H; Cardona S; Galindo RJ; Fayfman M; Davis G; Vellanki P; Migdal A; Gujral U; Narayan KMV; Umpierrez GE
    Diabetes Care; 2020 Feb; 43(2):349-357. PubMed ID: 31704689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period.
    Wu XY; She DM; Wang F; Guo G; Li R; Fang P; Li L; Zhou Y; Zhang KQ; Xue Y
    BMC Endocr Disord; 2020 Dec; 20(1):182. PubMed ID: 33317485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan: a multicenter retrospective cohort study.
    Takahashi K; Uenishi N; Sanui M; Uchino S; Yonezawa N; Takei T; Nishioka N; Kobayashi H; Otaka S; Yamamoto K; Yasuda H; Kosaka S; Tokunaga H; Fujiwara N; Kondo T; Ishida T; Komatsu T; Endo K; Moriyama T; Oyasu T; Hayakawa M; Hoshino A; Matsuyama T; Miyamoto Y; Yanagisawa A; Wakabayashi T; Ueda T; Komuro T; Sugimoto T; Lefor AK
    Acta Diabetol; 2024 Jan; 61(1):117-126. PubMed ID: 37728831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies.
    MacIsaac RJ; Lee LY; McNeil KJ; Tsalamandris C; Jerums G
    Intern Med J; 2002 Aug; 32(8):379-85. PubMed ID: 12162394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Diabetic Ketoacidosis With Hyperosmolarity: Clinical Characteristics and Outcomes.
    Agrawal S; Baird GL; Quintos JB; Reinert SE; Gopalakrishnan G; Boney CM; Topor LS
    Endocr Pract; 2018 Aug; 24(8):726-732. PubMed ID: 30084686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM.
    Zhang W; Chen J; Bi J; Ding N; Chen X; Wang Z; Jiao Y
    Front Endocrinol (Lausanne); 2022; 13():1084441. PubMed ID: 36686495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some characteristics of hyperglycaemic crisis differ between patients with and without COVID-19 at a safety-net hospital in a cross-sectional study.
    Shah A; Deak A; Allen S; Silfani E; Koppin C; Zisman-Ilani Y; Sirisena I; Rose C; Rubin D
    Ann Med; 2021 Dec; 53(1):1642-1645. PubMed ID: 34511013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes.
    Tittel SR; Sondern KM; Weyer M; Poeplau T; Sauer BM; Schebek M; Ludwig KH; Hammer F; Fröhlich-Reiterer E; Holl RW;
    Acta Diabetol; 2020 Oct; 57(10):1245-1253. PubMed ID: 32488499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship between ambient temperature and admissions for diabetic ketoacidosis and hyperglycemic hyperosmolar state: A 14-year time-series analysis.
    Lu CL; Chang HH; Chen HF; Ku LE; Chang YH; Shen HN; Li CY
    Environ Int; 2016 Sep; 94():642-648. PubMed ID: 27395337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe complications after initial management of hyperglycemic hyperosmolar syndrome and diabetic ketoacidosis with a standard diabetic ketoacidosis protocol.
    Nambam B; Menefee E; Gungor N; Mcvie R
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1141-1145. PubMed ID: 28988226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA).
    Dhatariya KK; Vellanki P
    Curr Diab Rep; 2017 May; 17(5):33. PubMed ID: 28364357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term case fatality rate and associated factors among inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 15-year period.
    Chen HF; Wang CY; Lee HY; See TT; Chen MH; Jiang JY; Lee MT; Li CY
    Intern Med; 2010; 49(8):729-37. PubMed ID: 20424362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic - The role of primary care in early diagnosis and prevention of severe diabetic decompensation.
    Pina H; Martins JD; Guerra S; Aragüés JM; Valadas C
    Prim Care Diabetes; 2023 Oct; 17(5):524-525. PubMed ID: 37353465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hyperglycaemic crises and their associated mortality in Jamaica.
    Chung ST; Perue GG; Johnson A; Younger N; Hoo CS; Pascoe RW; Boyne MS
    Diabetes Res Clin Pract; 2006 Aug; 73(2):184-90. PubMed ID: 16458989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19.
    Field BCT; Ruan Y; Várnai KA; Davies J; Ryder REJ; Gandhi R; Harris S; Nagi D; Patel D; Kempegowda P; Wild SH; Wilmot EG; Khunti K; Rea R; Narendran P;
    Diabetes Obes Metab; 2023 Jul; 25(7):2012-2022. PubMed ID: 37016487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory biomarkers predict higher risk of hyperglycemic crises but not outcomes in diabetic patients with COVID-19.
    Tao LC; Shu H; Wang Y; Hou Q; Li JJ; Huang XL; Hua F
    Front Endocrinol (Lausanne); 2024; 15():1287795. PubMed ID: 38455656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profiles of hyperglycemic crises: A single-center retrospective study from Japan.
    Nishikawa T; Kinoshita H; Ono K; Kodama-Hashimoto S; Kobayashi Y; Nakamura T; Yoshinaga T; Ohkubo Y; Harada M; Toyonaga T; Takahashi T; Araki E
    J Diabetes Investig; 2021 Aug; 12(8):1359-1366. PubMed ID: 33277786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.
    Chan KH; Thimmareddygari D; Ramahi A; Atallah L; Baranetsky NG; Slim J
    Diabetes Res Clin Pract; 2020 Aug; 166():108279. PubMed ID: 32592843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.